ALL
-
2018.02.27
News
Announcement about Nomination of New Board of Directors
-
2018.02.13
News
Announcement of Strategic Investment in GAIA BioMedicine Inc.
-
2018.01.17
News
Announcement about Clinical Research on Transplantation of Allogenic iPSC Derived RPE Cell Suspension in Subjects with AMD
-
2018.01.09
Topics
Presentation at 2018 J.P. Morgan Healthcare Conference on Jan. 10, 2018 (Wed)
-
2017.09.27
Topics
Presentation at Cell and Gene Meeting on the Mesa
-
2017.06.05
Topics
Holding a Focus Session in ISSCR 2017 in Boston
-
2017.05.17
News
[Press Release] Universal Cells, Inc’s Gene Editing Strategy Published in Nature Biotechnology
-
2017.03.23
News
[Press Release] The Results from Athersys’ Phase 2 Trial of MultiStem Cell Therapy for Treating Ischemic Stroke Patients in the United States and Europe Published in Lancet Neurology
-
2017.01.31
News
[Press Release]Announcement on transfer of business relating to ophthalmic surgical adjuvant containing BBG250
-
2017.01.11
News
Presentation at 2017 JP Morgan Healthcare Conference on Wednesday January 11, 2017 at 4:00pm PT (Webcast available)
-
2018.03.01
News
Appointment of Dr. Masayo Takahashi as Special Advisor to Healios
-
2018.02.27
News
Announcement about Nomination of New Board of Directors
-
2018.02.13
News
Announcement of Strategic Investment in GAIA BioMedicine Inc.
-
2018.01.17
News
Announcement about Clinical Research on Transplantation of Allogenic iPSC Derived RPE Cell Suspension in Subjects with AMD
-
2018.01.09
News
Presentation at 2018 J.P. Morgan Healthcare Conference on Jan. 10, 2018 (Wed)
-
2017.09.27
News
Presentation at Cell and Gene Meeting on the Mesa
-
2017.06.05
News
Holding a Focus Session in ISSCR 2017 in Boston
-
2017.05.17
News
[Press Release] Universal Cells, Inc’s Gene Editing Strategy Published in Nature Biotechnology
-
2017.03.23
News
[Press Release] The Results from Athersys’ Phase 2 Trial of MultiStem Cell Therapy for Treating Ischemic Stroke Patients in the United States and Europe Published in Lancet Neurology
-
2017.01.31
News
[Press Release]Announcement on transfer of business relating to ophthalmic surgical adjuvant containing BBG250